ClinicalTrials.Veeva

Menu

Study on Optimal Oxygen Concentration During Pulmonary Rehabilitation

N

National Hospital Organization Minami Kyoto Hospital

Status

Enrolling

Conditions

Chronic Respiratory Failure
High-flow Nasal Cannula
Exercise Capacity
Optimal SpO2 Value

Treatments

Other: Low SpO2
Other: High-flow nasal cannula

Study type

Interventional

Funder types

Other

Identifiers

NCT04481295
2019-24

Details and patient eligibility

About

The purpose of this study is to compare the exercise capacity between high SpO2 (Minimum SpO2 94-96%) value during pulmonary rehabilitation and low SpO2 (Minimum SpO2 84-86%) value during pulmonary rehabilitation for the patients with chronic respiratory failure receiving long-term oxygen therapy.

Full description

In patients with chronic respiratory failure, pulmonary rehabilitation is recognized as an evidence-based treatment in improving exercise capacity, muscle strength, dyspnea, and quality of life. However, optimal SpO2 value during pulmonary rehabilitation in patients with chronic respiratory failure receiving long-term oxygen therapy is unclear.

The present study is randomized to compare the effect of exercise capacity between high SpO2 (Minimum SpO2 94-96%) value during pulmonary rehabilitation and low SpO2 (Minimum SpO2 84-86%) value during pulmonary rehabilitation for the patients with chronic respiratory failure receiving long-term oxygen therapy.

Enrollment

32 estimated patients

Sex

All

Ages

20 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects with chronic respiratory failure receiving long-term oxygen therapy for more than 3 months.

Exclusion criteria

  • Subjects with severe cardiovascular disease, liver disease, neurological disease, and renal failure.
  • Subjects with a history of hospitalization for pneumonia or exacerbation of respiratory failure within the last month.
  • Subjects with changes in LTOT prescription flow within the last month
  • Subjects who cannot undergo pulmonary rehabilitation due to severe heart failure, arteriosclerosis obliterans or spinal disease.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

32 participants in 2 patient groups

High SpO2 group
Active Comparator group
Description:
In this group, patients have undergone 4 weeks of pulmonary rehabilitation under the HFNC (FIO2 value that the minimum SpO2 value during pulmonary rehabilitation is 94-96%, and a flow of 10 L/min).
Treatment:
Other: High-flow nasal cannula
Low SpO2 group
Active Comparator group
Description:
In this group, patients have undergone 4 weeks of pulmonary rehabilitation under the HFNC (FIO2 value that the minimum SpO2 value during pulmonary rehabilitation is 84-86%, and a flow of 10 L/min).
Treatment:
Other: Low SpO2

Trial contacts and locations

1

Loading...

Central trial contact

Yuichi Chihara

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems